Peptide Medix product catalog

EG
News & Analysis

CagriSema and Amylin Analogs: Why Researchers Pair Cagrilintide with Semaglutide

Amylin and GLP-1 are different hormones acting at different receptors on partly shared circuits. That non-overlap is the entire rationale for pairing cagrilintide with semaglutide.

Editorial Team Aug 16, 2026 5 min read
EG
News & Analysis

The Next GLP-1s: Amycretin, Ecnoglutide, Orforglipron and Survodutide Compared

Four candidates, four different bets on what comes after semaglutide and tirzepatide. A receptor-level comparison of amycretin, ecnoglutide, orforglipron and survodutide for research selection.

Editorial Team Aug 16, 2026 4 min read
EG
News & Analysis

What 'Research Use Only' Means After the 2025–2026 FDA Enforcement Wave

RUO is a labeling and distribution category with a specific regulatory meaning. Here is what it covers, what it never covered, and what changed after 2025.

Editorial Team Aug 16, 2026 5 min read
EG
News & Analysis

Retatrutide Explained: What the Published Phase-3 Data Reported (2026 Update)

Retatrutide is a single peptide that engages three receptors. Here is what the published trials reported through 2026, what is still press-release only, and what that means for reference-standard sourcing.

Editorial Team Aug 16, 2026 5 min read
EG
News & Analysis

BPC-157 Research in 2026: What Has Been Studied, What Hasn't

The BPC-157 literature is large, consistent and almost entirely preclinical. Mapping what has been studied — and the specific gaps — is more useful than another summary of rodent results.

Editorial Team Aug 16, 2026 5 min read
EG
News & Analysis

Choosing a Research Peptide Vendor in 2026: 9 Things That Actually Matter

Purity percentages are the easiest thing to print and the hardest thing to verify. These nine checks look at what a supplier documents, not what it claims.

Editorial Team Aug 16, 2026 5 min read
EG
News & Analysis

CJC-1295, Ipamorelin, Sermorelin: The GH Secretagogue Landscape Explained

Sermorelin, CJC-1295, ipamorelin and the GHRPs are routinely lumped together. They divide cleanly into two receptor families that do different things to the same axis.

Editorial Team Aug 16, 2026 5 min read
EG
News & Analysis

GHK-Cu: 50 Years of Copper Peptide Research

GHK was isolated from human plasma in the early 1970s. Half a century later its copper complex is still the most-studied copper peptide, and its chemistry drives every handling decision.

Editorial Team Aug 16, 2026 5 min read
EG
News & Analysis

KLOW, GLOW and Wolverine: How Recovery Blends Are Composed

Three named recovery blends, three different component sets. The mass on the label tells you far less than the molar arithmetic and the blend COA do.

Editorial Team Aug 16, 2026 5 min read
EG
News & Analysis

Peptide Storage in Hot Weather: What Degrades and What Doesn't

A lyophilised cake tolerates summer transit far better than most buyers assume. A reconstituted solution does not. The difference is water, and it explains almost everything.

Editorial Team Aug 16, 2026 5 min read
EG
News & Analysis

How to Read a Peptide COA Like a Chemist

Most buyers read the purity number and stop. An analyst reads the method conditions, the charge-state series and the net peptide content — and that is where the information actually is.

Editorial Team Aug 16, 2026 5 min read
EG
News & Analysis

TB-500 vs Thymosin Beta-4: A Fragment Is Not the Whole Protein

Almost all the published thymosin beta-4 biology was generated with the full 43-residue protein, not the heptapeptide sold as TB-500. The molecular weights differ by a factor of five.

Editorial Team Aug 16, 2026 5 min read